Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
A Phase 2 study of MLN0264 in gastric and gastroesophageal junction adenocarcinoma expressing GC-C was terminated. Results were posted in Ma…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer [Phase 2]
A Phase 2 study evaluated trastuzumab in combination with capecitabine and oxaliplatin as first-line chemotherapy for inoperable, locally ad…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer [NA]
Completed clinical trial evaluating the clinical significance of circulating tumor cells in the blood of patients with advanced or metastati…
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. [Phase 2]
A Phase 2 trial evaluating apatinib combined with paclitaxel as second-line therapy for advanced gastric cancer is underway.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China
A prospective and observational cohort study assessing treatment model and economic aspects of chemotherapy for advanced gastric cancer in c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating the combination of docetaxel and S-1 as second-line therapy for adva…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating PD-1 knockout EBV-specific cytotoxic T lymphocytes for advanced EBV-associated malignancies, includ…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Gastric In Vivo Study [Phase 1]
A Phase 1 gastric cancer trial (Gastric In Vivo Study) has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer [NA]
A clinical trial evaluating extensive peritoneal lavage during gastric cancer surgery to eliminate peritoneal tumor cells has been terminate…
-
FDA approval · 2017-04-27FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for HERCEPTIN (trastuzumab) submitted by Genentech, Inc. The action pertains to a supplemental appro…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Her 2 Testing in Indian Patients With Gastric Cancer
A Tata Memorial Hospital-sponsored clinical trial evaluating HER2 testing in Indian patients with gastric cancer has been terminated.
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: A Clinical Research of CAR T Cells Targeting CEA Positive Cancer [Phase 1]
Phase 1 trial evaluating CAR T cells targeting CEA-positive cancers across multiple solid tumor indications.
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Endoscopic Resection Multicenter Registry
Clinical trial registry update for a multicenter study on endoscopic resection in gastrointestinal neoplasms, with the current status listed…
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Immunomodulating Nutrients in Perioperative Patients With Gastric Cancer [NA]
This update concerns a completed trial evaluating immunomodulating nutrients administered perioperatively to patients with gastric cancer.
-
CLINICAL_TRIALS research · 2017-04-17Clinical Trial Update: The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer [Phase 3]
Phase 3 clinical trial update examining whether adding dexmedetomidine improves postoperative sleep in middle-aged and elderly patients with…
-
CLINICAL_TRIALS research · 2017-04-17Clinical Trial Update: Laparoscopic Total Gastrectomy With Versus Without Bursectomy [Phase 2]
Phase 2 clinical trial comparing laparoscopic total gastrectomy with versus without bursectomy, sponsored by Guangdong Provincial Hospital o…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Quality of Life After Oesophageal or Gastric Cancer Surgery [NA]
This entry provides a completed status update for a clinical trial studying quality of life after oesophageal or gastric cancer surgery.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Study of Afuresertib Combined With Paclitaxel in Gastric Cancer [Phase 1]
A Phase 1 study evaluating the combination of afuresertib and paclitaxel for gastric cancer has been completed.
-
CLINICAL_TRIALS research · 2017-04-10Clinical Trial Update: Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection [Phase 2]
Phase 2 clinical trial comparing laparoscopic-assisted total gastrectomy versus open total gastrectomy with splenic hilum lymph node dissect…
-
FDA approval · 2017-03-30FDA Approved: LONSURF — Supplemental Application (Taiho Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for LONSURF (trifluridine and tipiracil) from Taiho Pharmaceutical, expanding its regulatory coverag…
-
FDA approval · 2017-03-27FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for HERCEPTIN (trastuzumab) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Study of ARQ 197 Monotherapy [Phase 2]
This update covers a completed Phase 2 study of tivantinib (ARQ 197) as monotherapy for gastric cancer sponsored by Kyowa Kirin.
-
CLINICAL_TRIALS withdrawal · 2017-03-14Clinical Trial Update: Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment [Phase 2]
A Phase 2 trial evaluating Afatinib in combination with weekly Paclitaxel as second-line therapy for HER-2 positive gastric and gastroesopha…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating E7050 plus cisplatin and capecitabine versus cisplatin and capecitabine in patients with advanced or metastatic…